home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410n.zip
/
M94A2635.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
2KB
|
34 lines
Document 2635
DOCN M94A2635
TI Cohort study of HIV infection among drug users in Ruili and other
counties in Yunnan Province, China.
DT 9412
AU Zheng XW; Zhang JP; Qu SQ; Institute of Epidemiology and Microbiology,
Chinese Academy of; Preventive Medicine, Beijing.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):26 (abstract no. 076C). Unique
Identifier : AIDSLINE ICA10/94369940
AB In 1993, a second survey was conducted in Ruili City and other two
counties in Yunnan Province, where a cohort study field had been
established in 1992. 755 drug users including both HIV+ and HIV-, 102
spouses of HIV infected IDUs were interviewed. 9 samples of 54 IDUs in
the cohort study tested were seroconverters. The seroconversion rates
(incidence rate) in IDUs (per hundred person year) in Ruili, Longchuan,
and Luxi were 40, 12.2 and 0 respectively in 1993. The rates in the same
area in 1992 were 43.2, 12.2 and 0. Among 108 subjects newly recruited
IDUs, 38 were tested HIV positive. The seroprevalence rates in these
three counties were 85.7%, 40.0% and 0 in 1993, in comparison to 81.8%,
44.6% and 5.1% in 1992. The coordination was observed in the levels
between seroconversion and seroprevalence. An increasing of
seroprevalence among the spouses of HIV infected IDUs was also found:
which was 3.1% in 1990; 9.8% in 1992 and 7.4% in 1993. More attention
should be paid to Luxi county where the ratio of IV drug use increased
rapidly among drug users, although fewer HIV positive subjects was found
among the recent starter of IDUs.
DE China/EPIDEMIOLOGY Cohort Studies Female Human HIV
Seropositivity/*DIAGNOSIS/EPIDEMIOLOGY *HIV Seroprevalence Incidence
Male Substance Abuse, Intravenous/*IMMUNOLOGY MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).